Medical Innovation Exchange

JPM23: Mirati's post-Krazati pipeline restock to focus on 'highest opportunity for capital'

https://www.fiercebiotech.com/biotech/jpm23-miratis-post-krazati-pipeline-restock-focus-highest-opportunity-capital

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!